'Breakthrough' lung cancer drug made available on NHS

'Breakthrough' lung cancer drug made available on NHS
 

A last-chance drug that can lead to an “unprecedented” reduction in lung cancer tumours has become available on the NHS.
Tagrisso (osimertinib) was granted a licence only in February and has been hailed as a breakthrough drug by manufacturer AstraZeneca.
The once-a-day tablet will be available immediately for patients with non-small-cell lung cancer who have a specific mutation, known as EGFR T790M-positive, that means they have stopped responding to earlier treatments. Experts predict about 300 patients in England and Wales will be eligible for Tagrisso every year.
The National Institute... read more

 
4 October 2016 in Health, Views: 48
Source: Guardian
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31